Earnings Call Intelligence Subscribe
Home › Credibility Index › CSBR
Management credibility scorecard

Champions Oncology (CSBR)

1 quarters tracked (Q1'27 to Q1'27) · latest call September 10, 2026
Get the next CSBR call sheet
n/a
No resolved promises yet
0
Kept or exceeded
0
Missed
3
Still pending
Share count, 3 yrs/yr · flat

Score History

QuarterCall dateDisclosureFinancial qualityKeptMissed
Q1'27September 10, 2026--00Call sheet →
Disclosure: the 6-item rubric, each scored 0-2, out of 12. Financial quality: flagged indicators by severity. Kept and missed count the prior-quarter promises scored on that call.

Promise Ledger · All Quarters

MarkedStatusPromise
Q1'27PendingJuly 27, 2026: deliver a strong FY2027 and report progress quarterly.
Revenue and adjusted EBITDA improved, but operating cash flow weakened.
Q1'27PendingJuly 27, 2026: FY2027 budget assumes Corellia funding for the full year.
External discussions continue; no funding outcome announced.
Q1'27PendingJuly 27, 2026: expected Q4 data revenue shifted into Q1 FY2027, including a larger agreement.
Q1 data revenue was $893,000, without contract attribution.
Each row is a promise from the prior call, scored against the quarter in "Marked". Kept-promise rate counts resolved promises only; pending is excluded.
Promise-kept rate counts resolved promises only (pending excluded).
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.